Enovis Income After Taxes 2010-2024 | ENOV
Enovis income after taxes from 2010 to 2024. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
| Enovis Annual Income After Taxes (Millions of US $) |
|
|---|---|
| 2024 | $-827 |
| 2023 | $-54 |
| 2022 | $-38 |
| 2021 | $-102 |
| 2020 | $-74 |
| 2019 | $19 |
| 2018 | $122 |
| 2017 | $46 |
| 2016 | $155 |
| 2015 | $177 |
| 2014 | $420 |
| 2013 | $209 |
| 2012 | $-42 |
| 2011 | $5 |
| 2010 | $16 |
| 2009 | $24 |
| Enovis Quarterly Income After Taxes (Millions of US $) |
|
|---|---|
| 2024-12-31 | $-704 |
| 2024-09-30 | $-34 |
| 2024-06-30 | $-18 |
| 2024-03-31 | $-72 |
| 2023-12-31 | $3 |
| 2023-09-30 | $-19 |
| 2023-06-30 | $-15 |
| 2023-03-31 | $-23 |
| 2022-12-31 | $-55 |
| 2022-09-30 | $-66 |
| 2022-06-30 | $121 |
| 2022-03-31 | $-38 |
| 2021-12-31 | $-74 |
| 2021-09-30 | $-14 |
| 2021-06-30 | $-42 |
| 2021-03-31 | $28 |
| 2020-12-31 | $-97 |
| 2020-09-30 | $17 |
| 2020-06-30 | $-3 |
| 2020-03-31 | $9 |
| 2019-12-31 | $34 |
| 2019-09-30 | $4 |
| 2019-06-30 | $2 |
| 2019-03-31 | $-22 |
| 2018-12-31 | $25 |
| 2018-09-30 | $17 |
| 2018-06-30 | $48 |
| 2018-03-31 | $32 |
| 2017-12-31 | $-84 |
| 2017-09-30 | $50 |
| 2017-06-30 | $42 |
| 2017-03-31 | $38 |
| 2016-12-31 | $44 |
| 2016-09-30 | $41 |
| 2016-06-30 | $44 |
| 2016-03-31 | $26 |
| 2015-12-31 | $38 |
| 2015-09-30 | $24 |
| 2015-06-30 | $59 |
| 2015-03-31 | $56 |
| 2014-12-31 | $86 |
| 2014-09-30 | $81 |
| 2014-06-30 | $198 |
| 2014-03-31 | $55 |
| 2013-12-31 | $44 |
| 2013-09-30 | $65 |
| 2013-06-30 | $67 |
| 2013-03-31 | $32 |
| 2012-12-31 | $25 |
| 2012-09-30 | $14 |
| 2012-06-30 | $19 |
| 2012-03-31 | $-100 |
| 2011-12-31 | $-16 |
| 2011-09-30 | $4 |
| 2011-06-30 | $10 |
| 2011-03-31 | $7 |
| 2010-12-31 | $9 |
| 2010-09-30 | $6 |
| 2010-06-30 | $2 |
| 2010-03-31 | $0 |
| 2009-12-31 | $7 |
| 2009-09-30 | $6 |
| 2009-06-30 | $4 |
| 2009-03-31 | $7 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.825B | $2.108B |
| Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $35.134B | 48.53 |
| Tempus AI (TEM) | United States | $6.966B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $6.050B | 97.25 |
| Inspire Medical Systems (INSP) | United States | $4.470B | 86.83 |
| IRhythm Technologies (IRTC) | United States | $3.223B | 0.00 |
| Privia Health (PRVA) | United States | $2.873B | 215.27 |
| Schrodinger (SDGR) | United States | $1.881B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.839B | 0.00 |
| Omnicell (OMCL) | United States | $1.418B | 30.59 |
| Phreesia (PHR) | United States | $1.409B | 0.00 |
| Azenta (AZTA) | United States | $1.154B | 53.72 |
| 10x Genomics (TXG) | United States | $0.918B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.568B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.551B | 0.00 |
| Talkspace (TALK) | United States | $0.450B | 267.00 |
| Veradigm (MDRX) | United States | $0.449B | 0.00 |
| Standard BioTools (LAB) | United States | $0.440B | 0.00 |
| TruBridge (TBRG) | United States | $0.363B | 0.00 |
| Claritev (CTEV) | United States | $0.325B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.270B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.206B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.189B | 0.00 |
| Pulmonx (LUNG) | United States | $0.182B | 0.00 |
| American Well (AMWL) | United States | $0.109B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.100B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.082B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.076B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.066B | 0.00 |
| 111 (YI) | China | $0.064B | 0.00 |
| CareCloud (CCLD) | United States | $0.060B | 2.58 |
| HeartBeam (BEAT) | United States | $0.055B | 0.00 |
| Outset Medical (OM) | United States | $0.040B | 0.00 |
| Zepp Health (ZEPP) | China | $0.039B | 0.00 |
| Zhongchao (ZCMD) | China | $0.030B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Syra Health (SYRA) | United States | $0.001B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |